iCup DX

141210 141425 141561 141870 141994 142126 143608 144152 144218 145067 150105 150167 151215 150976 141844 141929 142258 142314 143606 144511 145058 145059 150549 150867 150919 150920 151179 151190 151255 151338 151476 144377 150101 150285 150420 151161 151399 151696 144209 144463 150018 150107 150690 150883 141492 141519 141552 141726

Clinical Chemistry and Clinical Toxicology Devices

2

No

Worldwide Distribution - US (nationwide) and Internationally to Australia.

iCup Drug Screen Cup, Item No. I-DXA-187-016, I-DXA-167-013; || iCup DX 10 Panel w/Adulterant, Item No. I-DXA-1107-142; || iCup DX 11 Panel w/Adulterant, Item No. I-DXA-1117-131; || iCup DX 12 Panel w/Adulterant, Item No. I-DXA-1127-023; || iCup DX 6 Panel w/Adulterant, Item No. I-DXA-167-013; || iCup DX 8 Panel w/Adulterant, Item No. I-DXA-187-016; || iCup DX Drug Screen, Item No. I-DXA-1127-023 || These Drugs of Abuse Tests are one-step immunoassays for the qualitative detection of multiple drugs and drug metabolites in human urine. The configurations of these Drugs of Abuse Tests consist of a combination of drug strips, including Benzodiazepine (BZO). They are used to obtain a visual, qualitative result and are intended for professional and point of care use. || ¿¿¿